R&D News | pharmaphorum

News

MSD's enlicitide scores in hypercholesterolaemia, as Ionis lines up broader use for recent approval Tryngolza in severe hypertriglyceridaemia.

News

A prominent critic of RFK Jr's approach to vaccination regulation, Dr Paul Offit, has been removed from an influential FDA advisory committee.

News

No fewer than nine former directors of the CDC have said every American should be alarmed at what is happening on HHS Secretary Kennedy's watch.

News

UK biotech OMass has revealed its first major pharma partnership, with Roche paying $20m upfront for an inflammatory bowel disease programme.

News

A Newcastle University project that gauges whether health technologies can deliver real changes to the NHS has claimed £22m in UK government funding.

News

Bayer and MSD's hopes of expanding the use of Verquvo in heart failure have been dashed by a failed phase 3 trial.